Partner with us
Evidence-based solutions designed to improve health knowledge and decision making
NPS MedicineWise was established in 1998 as the National Prescribing Service (NPS) Limited. Through two decades of continuous national leadership and services provided in the health sector, NPS MedicineWise remains committed to supporting quality use of medicines to improve health decisions and health and economic outcomes in Australia.
Independent. Not-for-profit. Evidence-based. Consumer-centred.
Improve the health of Australians.
Improve health through safe and wise use of medicines and other health technologies.
Established in 1998 with the primary aim of promoting quality use of medicines, today we have grown to connect with health consumers and health professionals nation-wide, changing attitudes and behaviours, and empowering all Australians to make the best possible healthcare decisions when they count.
NPS MedicineWise is committed to reconciliation with Aboriginal and Torres Strait Islander people.
To help us deliver on that commitment, we have a Reconciliation Action Plan (RAP), endorsed by Reconciliation Australia. Our RAP outlines actions, responsibilities, targets and timelines across a range of themes for achieving our vision of reconciliation, and offers opportunities for everyone across NPS MedicineWise to get involved.
Our vision is to improve the health of Australians.
Our mission is to improve health through safe and wise use of medicines and other health technologies.
We add value as the steward of quality use of medicines: promoting safe and wise use of medicines; bridging gaps between evidence and practice; and enabling better decisions.
We aim to:
Our focus over the next two years is to:
We will achieve this by focusing on five priorities:
1. Drive strong national stewardship of quality use of medicines
2. Target quality use of medicines where the need or opportunity is greatest
3. Optimise the use of health insights
4. Improve our accountability, effectiveness and efficiency
5. Strengthen our financial sustainability
NPS MedicineWise is the steward for quality use of medicines and medical tests (generally abbreviated as QUM) in Australia and delivers on the QUM objectives of Australia’s National Medicines Policy.
Ultimately, we seek to improve the health of Australians through the safe and wise use of medicines and health technologies by building the health literacy of Australians and improving use of medicines and other health technologies while contributing to the sustainability of our health system.
Improving quality use of medicines and medical tests
NPS MedicineWise is funded by the Australian Government Department of Health through the Quality Use of Diagnostics, Therapeutics and Pathology Program to improve the way medicines and medical tests are prescribed and used (QUM grant).
NPS MedicineWise contributes to the implementation of the National Medicines Policy and the National Strategy for Quality Use of Medicines (NSQUM), by:
Our work is grounded in the principles of the National Strategy for Quality Use of Medicines, which are:
Through the Commonwealth QUM grant we improve quality use of therapeutics, diagnostics and pathology for Australian consumers and health professionals, facilitate free access to information to support appropriate use of therapeutics, diagnostics and pathology; and support the effectiveness and efficiency of the health system.
We strive to achieve the following:
QUM Grant priorities 2020-22
All activities under our QUM grant ultimately aim to improve the health of Australians through the safe and wise use of medicines and other health technologies.
Leveraging cross-sector collaboration and partnerships, our priorities include the following:
Biologic disease-modifying anti-rheumatic drugs (bDMARDs)
NPS MedicineWise leads a consortium of health organisations funded under the Australian Government’s Value in Prescribing Program to collaboratively improve the use of bDMARDs, support specialist prescribers and help consumers get the most benefit from these complex medicines.
Under the Australian Government’s Value in Prescribing Program, NPS MedicineWise and a consortium of health organisations is working nationally to improve health outcomes for patients prescribed immunoglobulin products.
We are working with the National Blood Authority and a range of stakeholders to develop and deliver educational resources, tools and interventions to support clinicians in optimising the use of precious immunoglobulin products, as well educate consumers on these products.
We offer evidence-based solutions designed to improve health knowledge and decision making.
Our team of experts is specialised in structuring and co-designing programs and products to meet different health research, policy making, health system and primary care needs.